Synthetic HDL Nanoparticles Delivering Docetaxel and CpG for Chemoimmunotherapy of Colon Adenocarcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synthetic HDL Nanoparticles Delivering Docetaxel and CpG for Chemoimmunotherapy of Colon Adenocarcinoma
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 5, Pages 1777
Publisher
MDPI AG
Online
2020-03-06
DOI
10.3390/ijms21051777
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High-Density Lipoprotein-Mimicking Nanodiscs for Chemo-immunotherapy against Glioblastoma Multiforme
- (2019) Padma Kadiyala et al. ACS Nano
- Engineering patient-specific cancer immunotherapies
- (2019) Lindsay Scheetz et al. Nature Biomedical Engineering
- Subcutaneous Nanodisc Vaccination with Neoantigens for Combination Cancer Immunotherapy
- (2018) Rui Kuai et al. BIOCONJUGATE CHEMISTRY
- Dual TLR agonist nanodiscs as a strong adjuvant system for vaccines and immunotherapy
- (2018) Rui Kuai et al. JOURNAL OF CONTROLLED RELEASE
- Elimination of established tumors with nanodisc-based combination chemoimmunotherapy
- (2018) Rui Kuai et al. Science Advances
- HDL in Endocrine Carcinomas: Biomarker, Drug Carrier, and Potential Therapeutic
- (2018) Emily E. Morin et al. Frontiers in Endocrinology
- Synthetic high-density lipoprotein nanodisks for targeted withalongolide delivery to adrenocortical carcinoma
- (2017) Rui Kuai et al. International Journal of Nanomedicine
- Effect of size and pegylation of liposomes and peptide-based synthetic lipoproteins on tumor targeting
- (2017) Jie Tang et al. Nanomedicine-Nanotechnology Biology and Medicine
- Myeloid-specific genetic ablation of ATP-binding cassette transporter ABCA1 is protective against cancer
- (2017) Maryam Zamanian-Daryoush et al. Oncotarget
- High-Density Lipoproteins: Nature’s Multifunctional Nanoparticles
- (2016) Rui Kuai et al. ACS Nano
- Symptomatic and Asymptomatic Colon Cancer Recurrence: A Multicenter Cohort Study
- (2016) L. A. M. Duineveld et al. ANNALS OF FAMILY MEDICINE
- Ursolic acid-loaded chitosan nanoparticles induce potent anti-angiogenesis in tumor
- (2016) Hua Jin et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Targeting dendritic cells in lymph node with an antigen peptide-based nanovaccine for cancer immunotherapy
- (2016) Yuan Qian et al. BIOMATERIALS
- Synthetic high-density lipoproteins for delivery of 10-hydroxycamptothecin
- (2016) Yue Yuan et al. International Journal of Nanomedicine
- DAFODIL: A novel liposome-encapsulated synergistic combination of doxorubicin and 5FU for low dose chemotherapy
- (2016) Kathryn M. Camacho et al. JOURNAL OF CONTROLLED RELEASE
- Designer vaccine nanodiscs for personalized cancer immunotherapy
- (2016) Rui Kuai et al. NATURE MATERIALS
- Synthetic high-density lipoprotein nanoparticles: A novel therapeutic strategy for adrenocortical carcinomas
- (2016) Chitra Subramanian et al. SURGERY
- Overexpression of apolipoprotein A-I fused to an anti-transforming growth factor beta peptide modulates the tumorigenicity and immunogenicity of mouse colon cancer cells
- (2015) José Medina-Echeverz et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Development of multifunctional lipid nanocapsules for the co-delivery of paclitaxel and CpG-ODN in the treatment of glioblastoma.
- (2015) Giovanna Lollo et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells
- (2015) Shi-Yong Li et al. JOURNAL OF CONTROLLED RELEASE
- Targeted Delivery of Small Interfering RNA Using Reconstituted High-Density Lipoprotein Nanoparticles
- (2015) Mian M.K. Shahzad et al. NEOPLASIA
- Update on current and potential nanoparticle cancer therapies
- (2013) Jonathan S. Rink et al. CURRENT OPINION IN ONCOLOGY
- Tumor targeting effects of a novel modified paclitaxel-loaded discoidal mimic high density lipoproteins
- (2013) Ji Wang et al. DRUG DELIVERY
- Biomimetic, synthetic HDL nanostructures for lymphoma
- (2013) S. Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Scavenger Receptor B1 is a Potential Biomarker of Human Nasopharyngeal Carcinoma and Its Growth is Inhibited by HDL-mimetic Nanoparticles
- (2013) Ying Zheng et al. Theranostics
- Targeting endogenous apo A-I—a new approach for raising HDL
- (2011) Prediman K. Shah Nature Reviews Cardiology
- Anti-tumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumour-associated macrophages
- (2010) Ilia N. Buhtoiarov et al. IMMUNOLOGY
- Evaluation of synthetic/reconstituted high-density lipoproteins as delivery vehicles for paclitaxel
- (2009) Walter J. McConathy et al. ANTI-CANCER DRUGS
- Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrier
- (2009) Linda K. Mooberry et al. JOURNAL OF DRUG TARGETING
- Alterations in cholesterol regulation contribute to the production of intratumoral androgens during progression to castration-resistant prostate cancer in a mouse xenograft model
- (2009) Carlos G. Leon et al. PROSTATE
- HDL-Mimicking Peptide-Lipid Nanoparticles with Improved Tumor Targeting
- (2009) Zhihong Zhang et al. Small
- Toll-like receptor 9 (TLR9) agonists in the treatment of cancer
- (2008) A M Krieg ONCOGENE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started